Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR T-cell surface antigen CD4 inhibitor PubMed

Cross References

Resources Reference
ChEMBL CHEMBL2109474